Skip to content
Biodatica
Start free

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Nanoro

OncologyPhase IIListed · MRK

This company trades under its own ticker, so it sits outside Biodatica’s pre-ticker window. The record stays here because its filings are real, but the feed leaves listed companies out unless you ask for them.

Sign in to watch

What changed

Phase II trial registered: Study of Pimicotinib in Japanese Participants With Tenosynovial Giant Cell Tumor (TGCT) (J-MANEUVER)

1w agoTrial registeredJul 10, 2026Source filing (opens the source filing in a new tab)

Momentum

89no change

Momentum 89 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    PHASE2 registered

    Mar 26, 2026

    Tenosynovial Giant Cell Tumor · RECRUITING · sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany · Study of Pimicotinib in Japanese Participants With Tenosynovial Giant Cell Tumor (TGCT) (J-MANEUVER)

    ClinicalTrials.gov · NCT07499362 (opens the source filing in a new tab)

  2. Trial

    PHASE1 registered

    Nov 24, 2025

    Fertility · COMPLETED · sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany · An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin

    ClinicalTrials.gov · NCT07269327 (opens the source filing in a new tab)

  3. Trial

    PHASE2 registered

    Mar 29, 2023

    Acute Malaria · COMPLETED · sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany · Phase IIa Proof of Concept Study of M5717-Pyronaridine in Adults and Adolescents With Acute Uncomplicated Plasmodium Falciparum Malaria (CAPTURE 1)

    ClinicalTrials.gov · NCT05689047 (opens the source filing in a new tab)

  4. Trial

    PHASE1 registered

    Sep 26, 2022

    Healthy · COMPLETED · sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany · PK Study of Xevinapant (Debio 1143) in Healthy East Asian Participants

    ClinicalTrials.gov · NCT05519540 (opens the source filing in a new tab)

  5. Trial

    PHASE1 registered

    Aug 24, 2022

    Healthy · COMPLETED · sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany · Effect of Evobrutinib on Pharmacokinetics of a Combined Oral Contraceptive

    ClinicalTrials.gov · NCT07215806 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources